Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q2 2026 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2025 Net Income$22.39K$22.39K+342.4% vs Q2 2025 EPS Diluted$0.00$0.00— vs Q2 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Operating Cash Flowderived-$20,680N/M ended Nov 30, 2025 · filed Jan 9, 2026 · 40 d after period end